Total Cost Management

Total cost management is shifting from broad primary-care accountability toward specialty-led risk models and tighter utilization controls: Blue Cross NC’s Advanced Kidney Care program and Oshi Health’s GI model show payers moving CKD, ESRD, and GI spend into outcomes-based specialty partnerships, while CJR-X reinforces the need for episode-level data infrastructure to manage post-acute leakage and avoidable variation. At the same time, Medicare Advantage remains the dominant senior-market chassis—55% of eligible beneficiaries are enrolled in MA in 2026—but scrutiny is intensifying around whether risk-based contracts and prior authorization actually reduce waste or simply restrict access, with new pushback against CMS’s WISeR AI prior authorization model and OIG findings on high denial rates for LTACH and inpatient rehab. For ACOs, health systems, and payers, the strategic fault line is becoming clearer: winning VBC contracts will require specialty integration, real-time cost/utilization analytics, and clinically credible utilization management that can withstand regulatory and political scrutiny. Blue Cross NC AKC case study KFF Medicare Advantage trends